Human Longevity, Inc. and Celgene Cellular Therapeutics Sign License Agreement to Develop and Commercialize Placental Stem Cell Population, PSC-100 for Multiple Therapeutic Applications
Celgene Makes Equity Investment in HLI (LA JOLLA, CA) August 11, 2014—Human Longevity, Inc. (HLI), a genomics an...
Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist
(LA JOLLA, CA) July 29, 2014—Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therap...
- RT @Aging_Research 2014 dinner honors Sen Bill Nelson, Purdues Mitch Daniels, TEDMEDs J Walker & geneticist @JCVenter http://t.co/igV5yjYaZP
[1 week ago]
- @humanlongevity & @Celgene (CCT) Sign Agreement to Develop & Commercialize Placental Stem Cell Population PSC-100 http://t.co/6vq0YfUywU
[1 month ago]
- Franz Och PhD, Expert in Machine Learning & Machine Translation, Joins HLI as Chief Data Scientist http://t.co/68adl6pW1s #bigdata #genomics
[2 months ago]
- RT @RepScottPeters: Productive discussion w. San Diegan @JCVenter from @JCVenterInst @SciCmteDems hearing this am re: Medical Innovation.
[2 months ago]
Using the combined power of our core areas of expertise—genomics, informatics, and stem cell therapies, we are tackling one of the greatest medical/scientific and societal challenges—aging and aging related diseases. –Dr. J. Craig Venter
The global market for healthy human longevity is enormous with total healthcare expenditures in those 65 and older running well over $7 trillion. We believe that HLI’s unique science and technology, along with our business leadership, will positively impact the healthcare market with novel diagnostics and therapeutics. –Dr. Robert Hariri
HLI is going to change the way medicine is practiced by helping to shift to a more preventive, genomic-based medicine model which we believe will lower healthcare costs. Our goal is not necessarily lengthening life, but extending a healthier, high performing, more productive life span. –Dr. J. Craig Venter
Between 1910 and 2010 improvements in medicine and sanitation increased the human lifespan by 50 percent from 50 to 75 years. Today with the emergence of exponential technologies such as those being pioneered and advanced by HLI we have the potential to meaningfully extend the lifespan even further. –Dr. Peter H. Diamandis